Indonesian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
10 hasil
Process for promoting weight loss in overweight dogs
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION
The present invention relates to a process and product for promoting weight loss in overweight dogs, and more particularly to a process for supplementing a canine diet with L-carnitine to promote weight loss, improve body composition, and enhance satiety in the animal.
It
Composition for the prevention and/or treatment of disorders due to abnormal lipid metabolism, comprising propionyl L-carnitine and chitosan
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
The present invention relates to a composition suitable for the prevention and/or treatment of disorders due to abnormal lipid metabolism, such as hypercholesterolaemia, atherosclerosis, hyperlipidaemia and obesity, comprising as characterising active ingredients propionyl L-carnitine or a
Method for decreasing the appetite in bulimic, overweight individuals
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
SUMMARY OF THE INVENTION
The present invention relates to a method for controlling and decreasing the appetite in overweight individuals and to 5-hydroxytryptophan (5-HTP)-containing anorectic pharmaceutical compositions.
According to its broadest aspect the invention relates to the coordinated use
Carnitine carrier related protein-1
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The present invention is directed to polynucleotides encoding the Carnitine Carrier Related Protein-1 (CCRP-1) protein, fragments thereof, and the regulatory regions located at the 5'- and 3'-end of the CCRP-1 gene. The invention also concerns polypeptides encoded by the
Compositions and methods for reducing or preventing obesity
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The invention relates to nutrition of companion and other domestic animals. In particular, the invention provides compositions and methods in which isoflavones, conjugated linoleic acid, and L-carnitine are used alone or in combination in food, food supplements and the like,
Compositions and methods for reducing or preventing obesity
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The invention relates to nutrition of companion and other domestic animals. In particular, the invention provides compositions and methods in which isoflavones, conjugated linoleic acid, and L-carnitine are used alone or in combination in food, food supplements and the like,
.beta.-hydroxy-.gamma.-aminophosphonates and methods for the preparation and use thereof
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention is in the field of medicinal chemistry. In particular, the invention relates to carnitine analogs such as .beta.-hydroxy-.gamma.-aminophosphonates and .beta.-amino-.gamma.-aminophosphonates that inhibit carnitine acyltransferases,
.beta.-hydroxy-.gamma.-aminophosphonates and methods for the preparation and use thereof
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention is in the field of medicinal chemistry. In particular, the invention relates to carnitine analogs such as .beta.-hydroxy-.gamma.-aminophosphonates and .beta.-amino-.gamma.-aminophosphonates that inhibit carnitine acyltransferases,
Use of L-acetylcarnitine, L-isovalerylcarnitine, L-propionylcarnitine for increasing the levels of IGF-1
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention relates to a novel therapeutic use of L-acetylcarnitine, L-isovalerylcarnitine, L-propionylcarnitine or pharmacologically acceptable salts thereof for increasing the levels of IGF-1 (insulin-like growth factor 1) for the
Composition of skin external application containing ginseng berry extracts
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
This application is the U.S. national phase of International Application No. PCT/KR2008/003069, filed 30 May 2008, which designated the U.S. and claims priority to Korean Patent Application No. 10-2007-0053097, filed 31 May 2007, the entire contents of each of which are hereby incorporated by
Database tanaman obat terlengkap yang didukung oleh sains
- Bekerja dalam 55 bahasa
- Pengobatan herbal didukung oleh sains
- Pengenalan herbal melalui gambar
- Peta GPS interaktif - beri tag herba di lokasi (segera hadir)
- Baca publikasi ilmiah yang terkait dengan pencarian Anda
- Cari tanaman obat berdasarkan efeknya
- Atur minat Anda dan ikuti perkembangan berita, uji klinis, dan paten
Ketikkan gejala atau penyakit dan baca tentang jamu yang mungkin membantu, ketik jamu dan lihat penyakit dan gejala yang digunakan untuk melawannya.
* Semua informasi didasarkan pada penelitian ilmiah yang dipublikasikan
